https://www.selleckchem.com/pr....oducts/oprozomib-onx
8,95%CI1.2-6.3), hyperlipidemia (aOR2.3,95%CI1.3-4.1), oral sedative usage (aOR6.3,95%CI1.8-22.5), and vitamin D supplementation (aOR2.7,95%Cl1.3-6.. Thyroid disorders, cancer, type 2 diabetes, hyperlipidemia, sedatives, and vitamin D supplementation were found to be associated with OLP. Additional investigation is required to explore these associations, which could shed light on the potential mechanism of OLP and reinforce the idea that oral lesions could be predicative of previously undetected systemic conditions. Thyroid